Posted on 10/05/2021
Takeaways: Rayner’s fully preloaded RayOne Aspheric IOL has received NMPA approval for sale in China. RayOne Aspheric will be showcased at the 21st CSCRS from 3-5 June 2021 in Dalian. RayOne Aspheric offers a premium
Posted on 6/05/2021
Worthing, UK, 3 May 2021 – With the global rollout of the RayOne EMV™ intraocular lens to markets around the world, Rayner announces today an exciting new campaign intended to
Posted on 1/04/2021
Worthing, UK – Rayner, the only British manufacturer of intraocular lenses (IOLs), has been successfully awarded Authorised Economic Operator (AEO) status by HM Revenue & Customs. AEO status is an
Posted on 26/03/2021
New York, USA, March 26, 2021 – RayOne EMV, a new fully preloaded non-diffractive IOL, has received FDA approval. RayOne EMV was developed in collaboration with world renowned surgeon Professor
Posted on 21/01/2021
Worthing, UK – Following the recent approval of incorporation, Rayner is proud to announce its direct entry into the Canadian ophthalmology market. Led by Wade Allen, Director: Americas, Rayner Surgical
Posted on 22/10/2020
Worthing (UK) – Rayner, the manufacturer of the world’s first intraocular lens (IOL) and winner of the 2020 Queen’s Award for Enterprise (Innovation), announced today the launch of their updated
Posted on 21/09/2020
Rayner set to launch RayOne EMV in early October Worthing, UK, September 21st, 2020 – Rayner has announced the upcoming launch of RayOne EMV: a new fully preloaded non-diffractive IOL
Posted on 22/07/2020
For immediate release Worthing, UK, July 22, 2020 – Rayner, the only UK manufacturer of Intraocular Lenses (IOLs) for treating cataracts and a winner of the 2020 Queen’s Awards for
Posted on 4/06/2020
Rayner hosted its first surgeon clinical education webinar on 27 May 2020, with attendees from over 47 countries. Over the course of one hour, the three presenters spoke about returning
Posted on 22/05/2020
Wednesday 27th May (1 hour) Join an international panel of expert speakers as they share their experiences with premium trifocal intraocular lenses (IOLs), and discuss the importance of Patient Reported